Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 127 is a non-functional genomic sequence homologous to the 5S ribosomal RNA gene. While 5S rRNA is a highly conserved structural and functional component of the large subunit of the ribosome involved in protein synthesis[1][3][5], pseudogenes like RNA5SP127 do not result in a functional RNA or protein and are not considered "targets" in the sense of therapeutic targeting (such as receptors, enzymes, or transporters)[4]. These pseudogenes may retain high sequence similarity to the functional parent gene but lack biological activity, and there is no evidence that pseudogenes in the ribosomal RNA family like RNA5SP127 are involved in disease pathogenesis, drug interactions, or used as clinical biomarkers[4]. Key points: - RNA, 5S ribosomal pseudogene 127 is a processed pseudogene derived from the 5S ribosomal RNA gene family[4]. - It does not encode a functional product and thus is not a molecular target for drugs or therapies[4]. - The presence of "pseudogene" in the name and the lack of protein or functional RNA output means this should not be treated as a therapeutic target. - If you are looking for information on the functional 5S ribosomal RNA itself, refer to 5S rRNA, which is essential for ribosome structure and protein synthesis but is not a druggable target[1][3][5]. Is there something wrong with this target? Yes. RNA5SP127 is not a therapeutic target; it is a pseudogene and has no known drug interactions, mechanisms of action, biomarker relevance, or safety concerns. It should not be included in drug target lists or considered for structured therapeutic information[4]. If your interest is in ribosomal function or ribosomal RNA, you should focus on the functional 5S ribosomal RNA (5S rRNA) rather than its pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 127 (RNA5SP127).